GGrantIndex
Sort

326,823 grants matching clinical trial

Skeletal Disorders and Mineral Homeostasis Section

$2,277,622
Michael Collins · National Institute Of Dental & Craniofacial Research · ZIA · FY2018 · DE

Patterns of Survivors' Recovery Trajectories in the ICECAP Trial (POST-ICECAP)

$2,277,215
Sachin Agarwal · Columbia University Health Sciences · R01 · FY2024 · NS

Clinical & Research Informatics

$2,277,171
Chandan Sastry · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIH · FY2013 · HD

Molecular Analysis Of Leukocyte Activation By Chemoattractants

$2,277,012
Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI

COG NCTN Year 12 BIQSFP Progress Report

$2,276,944
Douglas S. Hawkins · Public Health Institute · U10 · FY2025 · CA

Identification of Prodromal Neurodegeneration in Serotonergic-Induced REM sleep Behavior Disorder

$2,276,803
Michael J Howell · University Of Minnesota · RF1 · FY2025 · AG

A Global Syphilis Vaccine Targeting Outer Membrane Proteins of Treponema pallidum

$2,276,756
Michael Anthony Moody · Duke University · U01 · FY2025 · AI

SPORE in Multiple Myeloma

$2,276,698
Kenneth C Anderson · Dana-Farber Cancer Inst · P50 · FY2019 · CA

Stellenbosch University Clinical Trials Unit (SUN-CTU)

$2,276,671
Mark Fredric Cotton · Stellenbosch University · UM1 · FY2020 · AI

PREVENTABLE Data Coordinating Center

$2,276,326
Bradley G Hammill · Duke University · U19 · FY2025 · AG

Clinical Development of Chimp Adenovirus Vectors

$2,276,038
Hildegund C. J. Ertl · Wistar Institute · U19 · FY2009 · AI

Cancer Research of Wisconsin and Northern Michigan (CROWN) Consortium

$2,276,003
Anthony J Jaslowski · St. Vincent Hospital · UG1 · FY2022 · CA

MD Anderson Cancer Center SPORE in Gastrointestinal Cancer

$2,275,719
Scott Kopetz · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA

CLINICAL STUDIES MANAGEMENT AND SUPPORT (CSMS) - SOLE SOURCE BRIDGE CONTRACT

$2,275,654
Huiqing You · Kai Research, Inc · N02 · FY2021 · HL

Radiation and checkpoint blockade for cancer immune therapy

$2,275,599
Robert H Vonderheide · University Of Pennsylvania · P01 · FY2021 · CA

Thalamic stimulation to prevent impaired consciousness in epilepsy

$2,275,519
Hal Blumenfeld · Yale University · UH3 · FY2021 · NS

Cardiovascular Clinical Section Studies

$2,275,056
Michael Sack · National Heart, Lung, And Blood Institute · ZIC · FY2023 · HL

Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study

$2,275,025
Reisa A. Sperling · Massachusetts General Hospital · P01 · FY2016 · AG

Lymphoma Specialized Program of Research Excellence

$2,274,964
University Of Iowa · P50 · FY2004 · CA

MSK SPORE in Genomic Instability in Breast Cancer

$2,274,787
Simon N Powell · Sloan-Kettering Inst Can Research · P50 · FY2021 · CA

MSK SPORE in Genomic Instability in Breast Cancer

$2,274,787
Simon N Powell · Sloan-Kettering Inst Can Research · P50 · FY2023 · CA

MSK SPORE in Genomic Instability in Breast Cancer

$2,274,787
Simon N Powell · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA

Complete Human Peptide- and MRM-Atlas

$2,274,767
Robert L Moritz · Institute For Systems Biology · RC2 · FY2009 · HG

Lymphoma Specialized Program of Research Excellence

$2,274,631
University Of Iowa · P50 · FY2005 · CA

Gulf South Minority/Underserved Clinical Trials Network (Gulf South M/U CTN)

$2,274,555
Augusto C Ochoa · Lsu Health Sciences Center · UG1 · FY2023 · CA